Christopher Heery - Net Worth and Insider Trading

Christopher Heery Net Worth

The estimated net worth of Christopher Heery is at least $446,862 dollars as of 2024-05-10. Christopher Heery is the CHIEF MEDICAL OFFICER of Arcellx Inc and owns about 8,938 shares of Arcellx Inc (ACLX) stock worth over $446,006. Christopher Heery is also the Chief Medical Officer of Precision BioSciences Inc and owns about 83 shares of Precision BioSciences Inc (DTIL) stock worth over $856. Details can be seen in Christopher Heery's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Heery has not made any transactions after 2024-05-01 and currently still holds the listed stock(s).

Transaction Summary of Christopher Heery

To

Christopher Heery Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Heery owns 2 companies in total, including Precision BioSciences Inc (DTIL) , and Arcellx Inc (ACLX) .

Click here to see the complete history of Christopher Heery’s form 4 insider trades.

Insider Ownership Summary of Christopher Heery

Ticker Comapny Transaction Date Type of Owner
DTIL Precision BioSciences Inc 2019-12-19 Chief Medical Officer
ACLX Arcellx Inc 2024-05-01 Chief Medical Officer

Christopher Heery Latest Holdings Summary

Christopher Heery currently owns a total of 2 stocks. Among these stocks, Christopher Heery owns 8,938 shares of Arcellx Inc (ACLX) as of May 1, 2024, with a value of $446,006 and a weighting of 99.81%. Christopher Heery also owns 83 shares of Precision BioSciences Inc (DTIL) as of December 19, 2019, with a value of $856 and a weighting of 0.19%.

Latest Holdings of Christopher Heery

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACLX Arcellx Inc 2024-05-01 8,938 49.90 446,006
DTIL Precision BioSciences Inc 2019-12-19 83 10.31 856

Holding Weightings of Christopher Heery


Christopher Heery Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Heery has made a total of 17 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Arcellx Inc is the sale of 18,168 shares on May 1, 2024, which brought Christopher Heery around $932,563.

According to the SEC Form 4 filings, Christopher Heery has made a total of 1 transactions in Precision BioSciences Inc (DTIL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Precision BioSciences Inc is the acquisition of 83 shares on December 19, 2019, which cost Christopher Heery around $30,019.

Insider Trading History of Christopher Heery

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Heery Trading Performance

GuruFocus tracks the stock performance after each of Christopher Heery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Heery is -52.69%. GuruFocus also compares Christopher Heery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Heery within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Heery's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Heery

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.66
Relative Return to S&P 500(%) -15.54

Christopher Heery Ownership Network

Ownership Network List of Christopher Heery

No Data

Ownership Network Relation of Christopher Heery


Christopher Heery Owned Company Details

What does Precision BioSciences Inc do?

Who are the key executives at Precision BioSciences Inc?

Christopher Heery is the Chief Medical Officer of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include Chief Medical Officer Alan List , director & President and CEO Michael Amoroso , and General Counsel Dario Scimeca .

Precision BioSciences Inc (DTIL) Insider Trades Summary

Over the past 18 months, Christopher Heery made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 63,115 shares made by Dario Scimeca , a net sale of 39,298 shares made by Alan List , and a net sale of 310,940 shares made by Michael Amoroso .

In summary, during the past 3 months, insiders sold 2,480 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 2,480 shares. During the past 18 months, 17,114 shares of Precision BioSciences Inc (DTIL) were sold and 3,667 shares were bought by its insiders, resulting in a net sale of 13,448 shares.

Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Precision BioSciences Inc Insider Transactions

No Available Data

Christopher Heery Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Heery. You might contact Christopher Heery via mailing address: C/o Precision Biosciences, Inc., 302 E. Pettigrew Street, Suite A-100, Durham Nc 27701.

Discussions on Christopher Heery

No discussions yet.